ArticlePharmaceuticals (Basel, Switzerland)2022

Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial-Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells.

Pedro Barrios-Bernal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.